- Home
- CDTX vs OSUR Comparison
CDTX vs OSUR Comparison
Compare CDTX & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- OSUR
- Stock Information
- Founded
- CDTX 2012
- OSUR 2000
- Country
- CDTX United States
- OSUR United States
- Employees
- CDTX N/A
- OSUR N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- OSUR Medical/Dental Instruments
- Sector
- CDTX Health Care
- OSUR Health Care
- Exchange
- CDTX Nasdaq
- OSUR Nasdaq
- Market Cap
- CDTX 259.0M
- OSUR 223.0M
- IPO Year
- CDTX 2015
- OSUR 1986
- Fundamental
- Price
- CDTX $21.69
- OSUR $3.00
- Analyst Decision
- CDTX Strong Buy
- OSUR Hold
- Analyst Count
- CDTX 8
- OSUR 2
- Target Price
- CDTX $38.00
- OSUR $5.50
- AVG Volume (30 Days)
- CDTX 164.0K
- OSUR 528.9K
- Earning Date
- CDTX 05-08-2025
- OSUR 05-07-2025
- Dividend Yield
- CDTX N/A
- OSUR N/A
- EPS Growth
- CDTX N/A
- OSUR N/A
- EPS
- CDTX N/A
- OSUR N/A
- Revenue
- CDTX $1,275,000.00
- OSUR $185,827,000.00
- Revenue This Year
- CDTX N/A
- OSUR N/A
- Revenue Next Year
- CDTX N/A
- OSUR $7.55
- P/E Ratio
- CDTX N/A
- OSUR N/A
- Revenue Growth
- CDTX N/A
- OSUR N/A
- 52 Week Low
- CDTX $10.14
- OSUR $2.69
- 52 Week High
- CDTX $28.42
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- CDTX 56.70
- OSUR 44.05
- Support Level
- CDTX $19.97
- OSUR $2.91
- Resistance Level
- CDTX $22.80
- OSUR $3.04
- Average True Range (ATR)
- CDTX 1.37
- OSUR 0.09
- MACD
- CDTX 0.29
- OSUR 0.02
- Stochastic Oscillator
- CDTX 74.55
- OSUR 55.77
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.